Source: FinanzNachrichten

Novus Scientific: Fully resorbable synthetic matrix offers improved safety for breast cancer patients undergoing immediate breast reconstruction

UPPSALA, Sweden, Nov. 21, 2018 /PRNewswire/ -- Using the synthetic and fully resorbable TIGRMatrix surgical mesh (Novus Scientific AB, Uppsala -- Sweden) improves the outcome in breast cancer pati...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Thomas Engstrom's photo - CEO of Novus Scientific

CEO

Thomas Engstrom

CEO Approval Rating

65/100

Read more